You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 137 No. 9, September 1977 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (47)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Fungal Meningitis With Miconazole

Stanley C. Deresinski, MD; Ralph B. Lilly, MD; H. B. Levine, PhD; John N. Galgiani, MD; David A. Stevens, MD

Arch Intern Med. 1977;137(9):1180-1185.


Abstract



Twelve patients with fungal meningitis (ten cases were due to Coccidioides immitis, two were from Cryptococcus neoformans) were treated with brief courses of intravenous (IV) miconazole. Eleven patients, including patients with severe, chronic disease, had been treated unsuccessfully with amphotericin B. Four patients also received miconazole injected directly into the CSF. The drug was well tolerated by any route, with mild reversible side effects. After IV administration the miconazole concentration in the CSF rarely exceeded the minimal inhibitory concentration (MIC) of the infecting organism. Intra-CSF administration of 20 mg generally produced levels above the MIC for 24 hours. Five of ten patients with coccidioidal meningitis responded clinically. Of these five, four received only IV miconazole; three relapsed after therapy was stopped. Miconazole appears promising as a treatment of fungal meningitis, but trials of longer duration might prevent relapse.

(Arch Intern Med 137:1180-1185, 1977)



Author Affiliations



From the Santa Clara Valley Medical Center, San Jose, Calif, and Stanford University, Stanford, Calif (Drs Deresinski, Galgiani, and Stevens); Good Samaritan Hospital, Phoenix, Ariz (Dr Lilly); and the US Naval Biomedical Research Laboratory, Oakland, Calif (Dr Levine).


Footnotes



Accepted for publication Oct 1, 1976.

Reprint requests to Division of Infectious Diseases, Santa Clara Valley Medical Center, 751 S Bascom Ave, San Jose, CA 95128 (Dr Stevens).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Coccidioidal Meningitis
Goldstein et al.
Clinical Infectious Diseases 2006;42:103-107.
ABSTRACT | FULL TEXT  

High-Dose Ketoconazole for Treatment of Fungal Infections of the Central Nervous System
CRAVEN et al.
ANN INTERN MED 1983;98:160-167.
ABSTRACT  

Treatment of Coccidioidomycosis With Miconazole
Hoeprich et al.
JAMA 1980;243:1923-1926.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.